|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0017887,
umls-concept:C0030705,
umls-concept:C0062068,
umls-concept:C0242231,
umls-concept:C0332282,
umls-concept:C0340288,
umls-concept:C0389995,
umls-concept:C0939485,
umls-concept:C1280500,
umls-concept:C1999216
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-3-27
|
|
pubmed:abstractText |
Recent studies have suggested that the Rho/Rho-kinase mediated pathway (Rho-kinase pathway) regulates the vasomotion of arteries in pathological conditions. However, it remains unclear regarding whether this pathway regulates the coronary vasomotion of atherosclerotic lesions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1346-9843
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
402-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16565555-1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine,
pubmed-meshheading:16565555-Aged,
pubmed-meshheading:16565555-Angina Pectoris,
pubmed-meshheading:16565555-Angiography,
pubmed-meshheading:16565555-Chest Pain,
pubmed-meshheading:16565555-Coronary Stenosis,
pubmed-meshheading:16565555-Coronary Vessels,
pubmed-meshheading:16565555-Enzyme Inhibitors,
pubmed-meshheading:16565555-Female,
pubmed-meshheading:16565555-Hemodynamics,
pubmed-meshheading:16565555-Humans,
pubmed-meshheading:16565555-Intracellular Signaling Peptides and Proteins,
pubmed-meshheading:16565555-Japan,
pubmed-meshheading:16565555-Male,
pubmed-meshheading:16565555-Middle Aged,
pubmed-meshheading:16565555-Nitroglycerin,
pubmed-meshheading:16565555-Protein-Serine-Threonine Kinases,
pubmed-meshheading:16565555-Vasodilation,
pubmed-meshheading:16565555-Vasodilator Agents,
pubmed-meshheading:16565555-rho-Associated Kinases
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris.
|
|
pubmed:affiliation |
Department of Internal Medicine and Cardiology, Tama-Nagayama Hospital, Nippon Medical School, Tokyo, Japan. otsuka@nms.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
